Evidence map›Paper›PMID 38234624›Full record

ArticleExperimental and therapeutic medicine2024

Efficacy and safety of olmesartan medoxomil‑amlodipine besylate tablets (Sevikar

Zhaoqiang Cui, Zhaohui Qiu, Wenli Cheng, Wei Hu, Genshan Ma, Xiaojun Cai, Yafei Jin, Yi Zhao, Liqun He, Ying Li and 30 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 20 institutions in 1 country.

Zhaoqiang CuiDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
Zhaohui QiuDepartment of Cardiology, Shanghai Tongren Hospital, Shanghai 200050, P.R. China.
Wenli ChengDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, P.R. China.
Wei HuDepartment of Cardiology, Central Hospital of Minhang District, Shanghai 201199, P.R. China.
Genshan MaDepartment of Cardiology, Zhongda Hospital Affiliated to Southeast University, Nanjing, Jiangsu 210009, P.R. China.
Xiaojun CaiDepartment of Cardiology, Jinan Central Hospital, Jinan, Shandong 250013, P.R. China.
Yafei JinDepartment of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510062, P.R. China.
Yi ZhaoDepartment of Cardiology, Dalian Jinzhou First People's Hospital, Dalian, Liaoning 116199, P.R. China.
Liqun HeDepartment of Cardiology, Wuhan No. 1 Hospital, Wuhan, Hubei 430030, P.R. China.
Ying LiDepartment of Cardiology, Shanghai East Hospital, Shanghai 200120, P.R. China.
Peili BuDepartment of Cardiology, Qilu Hospital of Shandong University, Jinan, Shandong 250063, P.R. China.
Xiaoping ChenDepartment of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan 610044, P.R. China.
Ruxing WangDepartment of Cardiology, Wuxi People's Hospital, Wuxi, Jiangsu 214023, P.R. China.
Lin ChenDepartment of Cardiology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510630, P.R. China.
Peng DongDepartment of Cardiology, Beijing Aviation General Hospital, Beijing 100123, P.R. China.
Liuliu FengDepartment of Cardiology, Shidong Hospital, Shanghai 200090, P.R. China.
Xuebin HanDepartment of Cardiology, Shanxi Cardiovascular Hospital (Shanxi Cardiovascular Diseases Institute), Taiyuan, Shanxi 030024, P.R. China.
Mei HongDepartment of Cardiology, Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210003, P.R. China.
Yinglong HouDepartment of Cardiology, Shandong First Medical University, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, 250014, P.R. China.
Minlei LiaoDepartment of Cardiology, Baoshan Branch, Shanghai General Hospital, Shanghai 201999, P.R. China.
Mingliang WangDepartment of Cardiology, Shanghai Putuo District People's Hospital, Shanghai 200060, P.R. China.
Xiaoyan WangDepartment of Cardiology, Hospital Affiliated Jiang Nan University, Wuxi, Jiangsu 214043, P.R. China.
Jianhong XieDepartment of Cardiology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 314408, P.R. China.
Yawei XuDepartment of Cardiology, Shanghai Tenth People's Hospital, Shanghai 200072, P.R. China.
Zhenxing WangDepartment of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu 210004, P.R. China.
Kai HuangDepartment of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430073, P.R. China.
Yongle LiDepartment of Cardiology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
Dongsheng LiDepartment of Cardiology, Wuhan Third Hospital, Wuhan, Hubei 430074, P.R. China.
Xiaojun JiDepartment of Cardiology, Wenzhou Central Hospital, Wenzhou, Zhejiang 325099, P.R. China.
Jing HuangDepartment of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China.
Jun WangDepartment of Cardiology, Jing'an District Central Hospital of Shanghai, Shanghai 200040, P.R. China.
Danhong FangDepartment of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325015, P.R. China.
Jian'an WangDepartment of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, P.R. China.
Lijiang TangDepartment of Cardiology, Zhejiang Hospital, Hangzhou, Zhejiang 310013, P.R. China.
Yingwu LiuDepartment of Cardiology, Tianjin Third Central Hospital, Tianjin 300170, P.R. China.
Guosheng FuDepartment of Cardiology, Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310020, P.R. China.
Juan DuMedical Department, Daiichi Sankyo (China) Holdings Co., Ltd., Shanghai 200040, P.R. China.
Ling WangMedical Department, Daiichi Sankyo (China) Holdings Co., Ltd., Shanghai 200040, P.R. China.
Mengqi LiuMedical Department, Daiichi Sankyo (China) Holdings Co., Ltd., Shanghai 200040, P.R. China.
Junbo GeDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
Tianjin Medical University General Hospital · CNAviation General Hospital · CNCapital Medical University · CNCentral Hospital of Putuo District · CNChongqing Medical University · CNDalian Jinzhou First People's Hospital · CNHuadong Hospital · CNHuazhong University of Science and Technology · CNJiangsu Province Hospital · CNJinan Central Hospital · CNJingzhou Central Hospital · CNMinhang District Central Hospital · CNQilu Hospital of Shandong University · CNSecond Affiliated Hospital of Nanjing Medical University · CNSecond Affiliated Hospital of Zhejiang University · CNShandong Provincial QianFoShan Hospital · CNShanghai First People's Hospital · CNShanghai Tenth People's Hospital · CNShanxi Cardiovascular Hospital · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Essential hypertension is a notable threat for the older (age, ≥65 years) population. However, to the best of our knowledge, a real-world study assessing olmesartan medoxomil-amlodipine besylate (OM-AML) tablets in older Chinese patients with essential hypertension has not been performed. Therefore, the present study aimed to evaluate the efficacy and safety of OM-AML tablets in these patients. A total of 463 older Chinese patients with essential hypertension treated with OM-AML (20/5 mg) tablets (Sevikar

Indexed as

adverse eventblood pressure targetessential hypertensionolmesartan medoxomil-amlodipine besylate tablet

Identifiers

PMID38234624
PMCPMC10790165
OpenAlexW4389337942

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.